Coronary Artery Ectasia Presenting With Recurrent Inferior Wall Myocardial Infarction

AbstractCoronary ectasia presenting as a recurrent inferior myocardial infarction has rarely been reported in the literature. Herein, we report a 61-year-old man who presented with persistent chest pain accompanied by ST segment elevation in the inferior ECG leads. Coronary angiography showed ectasia of the right coronary artery (RCA) and total occlusion from the middle RCA. Two stents were implanted separately in the middle and distal RCA. The patient was readmitted due to recurrent inferior wall infarction 15 months after discharge. He underwent primary percutaneous coronary intervention again, and coronary angiography showed massive thrombosis and in-stent re-stenosis. The thrombosis and re-stenosis were successfully treated using balloon angioplasty. The patient was discharged under medical therapy with aspirin and clopidogrel. There were no anginal symptoms during the 3 years of follow up

A Closed General Solution of the Probability Distribution Function for Three‐Dimensional Random Walk Processes

A closed general solution of the probability distribution function for three‐dimensional random walk processes is derived. In addition: (1) For the particular case of equal‐length displacements, the exact solution is compared with the Gaussian approximation for n=3, 5, and 10 steps. (2) The general solution is utilized in calculating the probability distribution of gamma‐ray energies resulting in the Cl35 (n, γ) Cl36 process. (3) For five unequal steps of fractional length: 0.582, 0.135, 0.131, 0.092, and 0.060 (which is somewhat characteristic of the fractional energies of gamma rays resulting from neutron capture), the exact solution is compared with a Gaussian, a modified Gaussian, and a five equal‐step approximation. (4) There are presented the specific solutions for all possible unequal‐length random displacements involving n=2, 3, and 4 steps.Peer Reviewedhttp://deepblue.lib.umich.edu/bitstream/2027.42/70032/2/JCPSA6-34-2-535-1.pd

Ringtone Regardless of P-Early-Media Tag

A user device placing a mobile originating call on a network using Real-time Transport Protocol (RTP) ignores P-Early-Media tags and session description protocol (SDP) in Session Initiation Protocol (SIP) packets received from the network after receiving a 180 Ringing alert packet indicating that the receiving device is ringing to minimize a delay in playing a ringback tone. The user device plays a local ringtone until the user device receives audio RTP packets containing Early Media. If the user device receives audio RTP packets containing Early Media before the call is connected, the user device plays the Early Media as a custom ringtone

Serum total antioxidant capacity reflects severity of illness in patients with severe sepsis

INTRODUCTION: We conducted the present study to evaluate the changes in serum total antioxidant capacity (TAC) in patients with severe sepsis and to investigate the association between serum TAC and clinical severity. METHOD: This was a prospective observational study involving a sample of patients who met established criteria for severe sepsis and were admitted to the emergency department of a university teaching hospital. Serum TAC was determined using the total radical-trapping antioxidant parameter method. The levels of TAC, uric acid, albumin, and bilirubin in sera were obtained in the emergency department and evaluated to determine whether there were any correlations between the major antioxidant biomarkers and clinical severity of sepsis. The Acute Physiology and Chronic Health Evaluation (APACHE) II score was used for clinical evaluation of the severity of sepsis. RESULTS: A total of 73 patients with sepsis, with a mean (± standard deviation) APACHE II score of 23.2 ± 8.2 and a mortality rate of 26.0%, were included. Seventy-six healthy individuals served as control individuals. Among the patients, serum TAC levels correlated significantly with APACHE II scores. Patients who died also had higher TAC than did those who survived. Serum uric acid levels correlated significantly with serum TAC and APACHE II scores in patients with severe sepsis. CONCLUSION: Elevated serum TAC level may reflect clinical severity of sepsis. In addition, serum uric acid levels appear to contribute importantly to the higher TAC levels observed in patients with severe sepsis

Early Detection of Tumor Response by FLT/MicroPET Imaging in a C26 Murine Colon Carcinoma Solid Tumor Animal Model

Fluorine-18 fluorodeoxyglucose (18F-FDG) positron emission tomography (PET) imaging demonstrated the change of glucose consumption of tumor cells, but problems with specificity and difficulties in early detection of tumor response to chemotherapy have led to the development of new PET tracers. Fluorine-18-fluorothymidine (18F-FLT) images cellular proliferation by entering the salvage pathway of DNA synthesis. In this study, we evaluate the early response of colon carcinoma to the chemotherapeutic drug, lipo-Dox, in C26 murine colorectal carcinoma-bearing mice by 18F-FDG and 18F-FLT. The male BALB/c mice were bilaterally inoculated with 1 × 105 and 1 × 106 C26 tumor cells per flank. Mice were intravenously treated with 10 mg/kg lipo-Dox at day 8 after 18F-FDG and 18F-FLT imaging. The biodistribution of 18F-FDG and 18F-FLT were followed by the microPET imaging at day 9. For the quantitative measurement of microPET imaging at day 9, 18F-FLT was superior to 18F-FDG for early detection of tumor response to Lipo-DOX at various tumor sizes (P < 0.05). The data of biodistribution showed similar results with those from the quantification of SUV (standard uptake value) by microPET imaging. The study indicates that 18F-FLT/microPET is a useful imaging modality for early detection of chemotherapy in the colorectal mouse model

Therapeutic protein expression platform of microbial system

A number of expression systems have been developed for the production of pharmaceutical products. Pichia pastoris and Escherichia coli expression system operate in our lab and express antibody fragment (scFv), cytokine, protein base adjuvant and vaccine and process enzyme. The expression platform are consisted of three part, first is strain generation , the second is fermentation process development in 250 ml fermentor and the last is process scale-up to 5 litter fermentor. Please click Additional Files below to see the full abstract

The microbial antibodies secretion expression platform with scale down fermentors

Therapeutic antibodies have become one of the most effective therapeutics for human diseases such as cancer, inflammation and viral infection. The production of antibody-based drugs using microbial expression systems is more cost effective with ease of gene manipulation compared to mammalian expression systems. In our team, antibody fragments (ex: BsAb, scFv and Fab) were produced from methylotrophic yeast Pichia pastoris secretion expression system with the AOX1 as driven promoter or E. coli secretion expression system. To achieve high production yield for both system, we investigated fermentation parameter such as base medium, induction medium, induction condition, feeding strategy and pH. For the 250 ml fermentor Pichia system, the nitrogen have been add into glycerol fed medium and/or methanol induction medium and also compared base-medium, buffered glycerol-complex medium (BMGY) and basal salt medium (BS). The highest scFv production was yielded from the basal salt medium as base medium, glycerol fed medium plus nitrogen and multiple carbon source methanol induction medium. This process can yielded over 500 mg/L scFv. After scale-up from 250 ml fermentor to 5L fermentor, the methanol fed-back control system also applied on the 5 L fermentor, can achieve 1.7 g/L scFv in 5 days. The E. coli expression process has passed through screening for high production yield clones in 2 ml deep-well then confirmed by using 250 ml flask scale. Feeding medium, DO, pH etc, parameters were investigated by parallel 250 ml-fermenter. The parameters from 250 ml fermentor were validated by using 5 L fermenter. Under this scale-up procedure, the antibody Fab was 100 folds production yield, production deep well stage at 1 mg/L, production from 250 ml fermentor stage is 50-100 mg/L and production 5 L fermentor stage is over 35-90 mg/L. Although different antibodies will result in different production yield, building a reliable platform to predict production yield from antibody cell clones under deep well and shake flask stage serves a good scale-down model for future scale-up prediction